作者: M. Parta , M. Goebel , M. Matloobi , C. Stager , D. M. Musher
DOI: 10.1128/JCM.00351-09
关键词:
摘要: Until a decade ago, clinicians could use epidemiological clues to select empirical therapy for methicillin-susceptible Staphylococcus aureus (MSSA) or methicillin-resistant S. (MRSA) ([5][1]). The emergence of MRSA as community pathogen and the documentation inferiority non-beta-